在类风湿关节炎中将单核苷酸多态性加入风险算法能否改善心血管疾病风险预测?一项临床风险评分的内部与外部验证
在353例类风湿关节炎(RA)患者中基因分型60个单核苷酸多态性(SNP),99例发生心血管疾病(CVD)。rs3184504、rs4773144、rs12190287和rs445925与新发CVD显著相关。临床预测模型含年龄、性别、体质指数、收缩压、高密度脂蛋白胆固醇和肌酐,曲线下面积(AUC)为0.74(P=0.03),内部验证AUC为0.76(P<0.01)。加入SNP的新模型含rs17011666、rs801426、年龄、总胆固醇和高密度脂蛋白胆固醇,AUC为0.77(P<0.01),表现略好。外部验证(n=297)显示临床模型拟合良好,而SNP模型拟合较差。
要点
- rs3184504、rs4773144、rs12190287和rs445925与RA患者新发CVD显著相关。
- 临床预测模型AUC为0.74,内部验证AUC为0.76。
- 加入SNP后模型AUC为0.77,外部验证SNP模型拟合较差。
核心结论
- 若干SNP与RA中的CVD相关;将SNP加入模型后风险预测略有改善,但临床相关性存疑;需要更大规模研究以更准确确定这些SNP对CVD风险预测算法的附加价值。
研究设计与样本
- 在353例RA患者中对60个SNP进行基因分型,采用逻辑回归和Cox回归分析识别与CVD(n=99)相关的SNP,构建临床变量预测模型并加入SNP探讨附加预测价值,两模型均进行内部验证,并在另一队列(n=297)中进行外部验证。
主要发现
- rs3184504、rs4773144、rs12190287和rs445925与新发CVD显著相关。
- 临床预测模型由年龄、性别、体质指数、收缩压、高密度脂蛋白胆固醇和肌酐组成,AUC为0.74(P=0.03);内部验证AUC为0.76(P<0.01)。
- 含SNP的新模型包含rs17011666、rs801426、年龄、总胆固醇和高密度脂蛋白胆固醇,AUC为0.77(P<0.01),表现略好。
- 外部验证显示临床模型拟合良好,而SNP模型拟合较差。
关键数值与推荐
- 临床预测模型AUC为0.74(P=0.03),内部验证AUC为0.76(P<0.01)。
- 含SNP模型AUC为0.77(P<0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要更大规模研究以更准确确定这些SNP对CVD风险预测算法的附加价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current risk algorithms do not accurately predict cardiovascular disease (CVD) risk in rheumatoid arthritis (RA). An area of interest is that of single-nucleotide polymorphisms (SNPs), of which several have been associated with CVD in the general population. We investigated whether these SNPs are associated with CVD in RA and whether SNPs could improve CVD risk prediction in RA. METHODS: Sixty SNPs were genotyped in 353 patients with RA. Logistic and Cox regression analyses were performed to identify SNPs that were associated with CVD (n = 99). A prediction model with clinical variables was made. SNPs were added to investigate the additional predictive value. Both models were internally validated. External validation was done in a separate cohort (n = 297). RESULTS: rs3184504, rs4773144, rs12190287, and rs445925 were significantly associated with new CVD. The clinical prediction model consisted of age, sex, body mass index, systolic blood pressure, high-density lipoprotein cholesterol (HDLc), and creatinine, with an area under the curve (AUC) of 0.74 (P = 0.03). Internal validation resulted in an AUC of 0.76 (P < 0.01). A new model was made including SNPs and resulted in a model with rs17011666 and rs801426, age, total cholesterol, and HDLc, which performed slightly better with an AUC of 0.77 (P < 0.01). External validation resulted in a good fit for the clinical model, but a poor fit for the SNP model. CONCLUSION: Several SNPs were associated with CVD in RA. Risk prediction slightly improved after adding SNPs to the models, but the clinical relevance is debatable. However, larger studies are needed to determine more accurately the additional value of these SNPs to CVD risk prediction algorithms.
引用
- Agca R, Popa CD, Heymans MW, et al. Does Adding Single-Nucleotide Polymorphisms to Risk Algorithms Improve Cardiovascular Disease Risk Prediction in Rheumatoid Arthritis? An Internal and External Validation of a Clinical Risk Score. Arthritis Care Res (Hoboken). 2024. PMID: 38923367. doi:10.1002/acr.25382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。